Chargement en cours...
Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone
PPARγ regulates both glucose metabolism and bone mass. Recent evidence suggests that the therapeutic modulation of PPARγ activity with anti-diabetic thiazolidinediones elicits unwanted effects on bone. In this study, the effects of rosiglitazone on the skeleton of growing (1 month), adult (6 month),...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2007
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2084459/ https://ncbi.nlm.nih.gov/pubmed/17332064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2006-1587 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|